Dozens of Genomic Variations May Drive COVID-19 Clinical Outcomes

A new study identifies dozens of genomic variations that may drive hard-to-predict differences in COVID-19 clinical outcomes. According to the work, genomic variants in four genes that are critical to SARS-CoV-2 infection, including the <i>ACE2</i> gene, were targets of natural selection and associated with health conditions seen in COVID-19 patients.

Related Keywords

Central African Republic ,United States ,Cameroon ,Central African ,Cameroonian ,Chao Zhang ,Sarah Tishkoff ,Yuanqing Feng ,Giorgio Sirugo ,Anurag Verma ,Alfredk Njamnshi ,Penn Integrates Knowledge University Professor ,Perelman School Of Medicine ,Proceedings Of The National Academy Sciences ,Cameroon University Of Yaound ,School Of Arts Sciences ,Penn Perelman School Of Medicine ,University Of Pennsylvania ,National Academy ,Perelman School ,Penn Medicine ,Penn Medicine Biobank ,East Asian ,